Medical imaging using radiation-based techniques such as fluoroscopy are regularly used to visualise the inside, or lumen, of blood vessels and organs of the body, with a particular interest in the arteries, veins, and the heart chambers. The global CT scan market exceeded US$7 billion p.a. in 2019.
Cancer in high-income countries is the leading cause of non-communicable disease deaths . Over 10 million cancer patients receive a range of radiotherapy treatments P.A. Patients that receive radiation underdosing or overdosing have a significantly greater probability of developing secondary malignancies or suffering significant collateral tissue or organ damage. By the end of 2020 the global market for medical radiotherapy treatments for cancer is forecast to exceed US$8.8 billion p.a.
Cardiovascular disease is the leading global cause of early death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. In the US alone, there are over one million angiograms for heart disease performed each year. The annual global angiography equipment market was valued at US$9.77 billion in 2017 and is projected to reach US$13.06 billion P.A. by 2023, at a CAGR of 5.0% during the forecast period.
The MOSkin Technology : the world’s most advanced, cost-effective, REAL-TIME radiation dosimeter/sensor product range. Developed and proven in multiple successful clinical tests over 8 years of extensive research and development in over 20 clinics and hospitals around the world including Australia, Italy, Brazil and Malaysia .
MOSkin is the next generation of dosimeter technology and has already been extensively tested and used in a wide range of radiation treatments for cancer and diagnostic radiology scans, including: